Search results for "Keeping tabs"
Spotlight on new drug candidates
Recent manufacturer trials assessed a small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist; a combo of a GLP-1 receptor agonist and a long-acting amylin analogue; and a triple GLP-1 receptor agonist, glucose-dependent insulinotropic polypeptide, and glucagon receptor agonist.
https://diabetes.acponline.org/archives/2025/07/11/5.htm
11 Jul 2025
Spotlight on GLP-1 RA risks in older patients
Recent articles analyzed the risks of migraines, age-related macular degeneration, and loss of skeletal muscle mass in patients taking glucagon-like peptide-1 receptor agonists (GLP-1 RAs) after age 65 years.
https://diabetes.acponline.org/archives/2025/06/13/5.htm
13 Jun 2025
Spotlight on diabetes prevention programs
Recent studies offered follow-up data and risk prediction tools from two long-standing programs to prevent progression from prediabetes to diabetes in the U.S. and the U.K.
https://diabetes.acponline.org/archives/2025/05/09/5.htm
9 May 2025
Spotlight on initiation of SGLT-2 inhibitors
One study found that initiation of a sodium-glucose cotransporter-2 (SGLT-2) inhibitor was associated with risk of infection of the genital tract but not the urinary tract compared to a glucagon-like peptide-1 receptor agonist, while another study indicated that a decline in estimated glomerular filtration rate without a drop in urine albumin-to-creatinine ratio could be a worrisome signal.
https://diabetes.acponline.org/archives/2025/04/11/5.htm
11 Apr 2025
Spotlight on SGLT-2 inhibitors and DKA
Recent studies measured rates of diabetic ketoacidosis (DKA) in patients taking sodium-glucose cotransporter-2 (SGLT-2) inhibitors by looking at hospital records, emergency surgery outcomes, and a clinic specializing in ketogenic diets.
https://diabetes.acponline.org/archives/2025/03/14/5.htm
14 Mar 2025
Spotlight on inpatient diabetes care
Recent studies looked at the use of continuous glucose monitoring and metformin in the hospital.
https://diabetes.acponline.org/archives/2025/02/14/5.htm
14 Feb 2025
Spotlight on interventions for the underserved
Project ECHO for diabetes lowered HbA1c levels in patients at federally qualified health centers, one study found, but another trial did not identify any improvements in glycemic control from providing patients on Medicaid with medically tailored meals.
https://diabetes.acponline.org/archives/2025/01/10/5.htm
10 Jan 2025
Spotlight on GLP-1 receptor agonists
Cost and access issues were the focus of multiple recent articles about glucagon-like peptide-1 (GLP-1) and dual glucose-dependent insulinotropic polypeptide receptor agonists, while the latest research on these drug classes highlighted their clinical benefits.
https://diabetes.acponline.org/archives/2024/12/13/5.htm
13 Dec 2024
Spotlight on younger-onset diabetes
One recent study found significantly elevated mortality risk in patients diagnosed with diabetes before age 40 years, while another reported high rates of diabetes remission among adolescents who underwent bariatric surgery. The NIH announced a large new study of youth-onset diabetes.
https://diabetes.acponline.org/archives/2024/11/08/5.htm
8 Nov 2024
Spotlight on liver health in diabetes
A review compared liver outcomes for most classes of diabetes drugs, while a retrospective study looked at glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors head to head. Another study offered a new score for metabolic dysfunction-associated steatotic liver disease.
https://diabetes.acponline.org/archives/2024/10/11/5.htm
11 Oct 2024
Spotlight on GLP-1 receptor agonists and suicidality
Several recent studies did not find an association between glucagon-like peptide-1 (GLP-1) receptor agonists and suicidality, but one analysis identified a potential risk in patients with mental health issues before starting semaglutide.
https://diabetes.acponline.org/archives/2024/09/13/5.htm
13 Sep 2024
Spotlight on perceptions of glycemic control
Patients' perceptions of their glycemic control may have more effect on their psychological well-being than actual glycemic measurements, according to two new studies.
https://diabetes.acponline.org/archives/2024/08/09/5.htm
9 Aug 2024
Spotlight on gut microbiota in diabetes
A forum and a narrative review summarized current knowledge about the connections between diabetes and gut microbiota, while a new study identified certain species within patients' microbiomes that could relate to diabetes.
https://diabetes.acponline.org/archives/2024/07/12/5.htm
12 Jul 2024
Spotlight on hypoglycemia in older patients
One recent study highlighted the problem of physical food insecurity and another identified predictors of impaired hypoglycemia awareness, both in older diabetes patients. A review suggested varying continuous glucose monitoring targets for older patients by their health status.
https://diabetes.acponline.org/archives/2024/06/14/5.htm
14 Jun 2024
Spotlight on limitations of the HbA1c test
A recent position statement called for use of one-hour glucose tolerance testing for diabetes diagnosis, a review described limitations of point-of-care HbA1c testing, and a study identified differences in the relationship between fasting glucose and HbA1c level by race, age, and sex.
https://diabetes.acponline.org/archives/2024/04/12/5.htm
12 Apr 2024
Spotlight on NAFLD
Recent studies looked at the risks associated with nonalcoholic fatty liver disease (NAFLD), also known as metabolic dysfunction-associated steatotic liver disease (MASLD), the effects of diabetes drugs on the condition, and whether machine learning can help identify patients at risk.
https://diabetes.acponline.org/archives/2024/03/08/5.htm
8 Mar 2024
Spotlight on comparisons within diabetes drug classes
One review found tirzepatide to have more effect on glycemic outcomes than other glucagon-like peptide-1 receptor agonists, while another showed several sodium-glucose cotransporter-2 inhibitors to have similar effects on cardiovascular outcomes.
https://diabetes.acponline.org/archives/2024/02/09/5.htm
9 Feb 2024
Spotlight on the 2024 Standards of Care
The American Diabetes Association made its annual updates to the Standards of Care in Diabetes, addressing newer drug classes and growing evidence for bariatric surgery and heart failure screening, among many other changes.
https://diabetes.acponline.org/archives/2024/01/12/5.htm
12 Jan 2024
Spotlight on glycemia and dementia
One study found reduced rates of dementia in patients with type 2 diabetes who took metformin, while another showed that impaired fasting glucose posed a cognitive risk, and a review compared diabetes drug classes for their effects on dementia risk.
https://diabetes.acponline.org/archives/2023/12/08/5.htm
8 Dec 2023
Spotlight on novel therapies for type 1 diabetes
Manufacturer trials reported the effects of weekly insulin and teplizumab in patients with type 1 diabetes, while recent reviews looked at preventing beta-cell loss with various therapeutics and using drugs approved for type 2 diabetes to combat chronic kidney disease in type 1.
https://diabetes.acponline.org/archives/2023/11/10/5.htm
10 Nov 2023